Bladder/urothelial
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Adjuvant and Neoadjuvant | |||||
| DD M-VAC | |||||
| M-VAC | |||||
| Bacillus calmette-guerin | |||||
| Chemoradiotherapy | |||||
| Metastatic | |||||
| Cisplatin + Gemcitabine | |||||
| DD M-VAC | |||||
| Maintenance | |||||
| Avelumab | |||||
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Adjuvant and Neoadjuvant | |||||
| DD M-VAC | |||||
| M-VAC | |||||
| Bacillus calmette-guerin | |||||
| Chemoradiotherapy | |||||
| Metastatic | |||||
| Cisplatin + Gemcitabine | |||||
| DD M-VAC | |||||
| Maintenance | |||||
| Avelumab | |||||
Groupe d'étude en oncologie du Québec